Investmark Advisory Group’s Clorox CLX Stock Holding History

Investmark Advisory Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-265	Closed	-$46K	–	132
2021 Q4	$46K	Buy	+265	New	+$44.2K	0.04%	166

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Investmark Advisory Group's CLX Position: Q1 2022 in Review

Investmark Advisory Group sold out of Clorox (CLX) in Q1 2022, closing a stake of 265 shares — an estimated $46K sold.

Investmark Advisory Group first reported a position in CLX in Q4 2021 and held it in 1 quarter. The position peaked at $46K in Q4 2021. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

Investmark Advisory Group reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
Investmark Advisory Group sold 265 Clorox shares in Q1 2022, an estimated $46K.
Investmark Advisory Group first reported a position in Clorox in Q4 2021 and held it in 1 quarter.
Investmark Advisory Group's Clorox position peaked at $46K in Q4 2021.
1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Investmark Advisory Group's 13F filing for Q1 2022, filed 3 May 2022.